Literature DB >> 19806664

A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin.

David J Gordon, Steven R Sloan, Jill L O de Jong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806664     DOI: 10.1002/ajh.21544

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Authors:  Jenny M Despotovic; Michele P Lambert; Jay H Herman; Terry B Gernsheimer; Keith R McCrae; Michael D Tarantino; James B Bussel
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

2.  Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Authors:  Christine W Bruggeman; Sietse Q Nagelkerke; Wendy Lau; Cedric Manlhiot; Masja de Haas; Robin van Bruggen; Brian W McCrindle; Rae S M Yeung; Taco W Kuijpers
Journal:  Blood Adv       Date:  2020-07-28

3.  Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases.

Authors:  Roberta Berard; Blair Whittemore; Rosie Scuccimarri
Journal:  Pediatr Rheumatol Online J       Date:  2012-04-16       Impact factor: 3.054

Review 4.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

5.  A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review.

Authors:  Na Yeon Kim; Joon Hwan Kim; Jin Suk Park; Soo Hyun Kim; Yeon Kyung Cho; Dong Hyun Cha; Ki Eun Kim; Myung Suh Kang; Kyung Ah Lim; Youn Ho Sheen
Journal:  Korean J Pediatr       Date:  2016-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.